Publications
- Stem cell therapies for diabetes
- Process Optimization in Autologous Stem Cell–Derived Islet Generation to Address Key Limitations for Scalability, Safety, and Efficacy
- Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors
- Scalable Bioreactor-based Suspension Approach to Generate Stem Cell–derived Islets From Healthy Donor-derived iPSCs
- AT7867 promotes pancreatic progenitor differentiation of human iPSCs
- Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation
- The Current Status of Allogenic Islet Cell Transplantation
- Complete Suspension Differentiation of Human Pluripotent Stem Cells into Pancreatic Islets Using Vertical Wheel® Bioreactors
- Suspension culture improves iPSC expansion and pluripotency phenotype
- Towards Early Prediction of Human iPSC Reprogramming Success
- Cell Characterization, Graft Evaluation, and Yield of Islet-Like Cells Differentiated From Patient-Derived iPSCs
- AT7867 promotes pancreatic progenitor differentiation of human iPSCs and accelerates diabetes reversal
- Stem Cell–Derived Islet Transplantation in Patients With Type 2 Diabetes: Can Diabetes Subtypes Guide Implementation?
- Evaluating the Potential for ABO-incompatible Islet Transplantation: Expression of ABH Antigens on Human Pancreata, Isolated Islets, and Embryonic Stem Cell-derived Islets
- Characterization of stem-cell-derived islets during differentiation and after implantation
- Opportunities and impediments of human pluripotent stem cell-derived islets in the treatment of diabetes
- Optimizing Generation of Stem Cell-Derived Islet Cells
- Current Status, Barriers, and Future Directions for Humanized Mouse Models to Evaluate Stem Cell–Based Islet Cell Transplant
- Tumor necrosis factor receptor superfamily member 25 (TNFRSF25) agonists in islet transplantation: Endogenous in vivo regulatory T cell expansion promotes prolonged allograft survival
- Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
- 5-Aza-2′-Deoxycytidine and Valproic Acid in Combination with CHIR99021 and A83-01 Induce Pluripotency Genes Expression in Human Adult Somatic Cells
- Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes